AC
AI Cancer Cure
Evidence Atlas, updating nightly
Trials
Research
Support
Alternatives
Cancers
Biomarkers
Updates
Roadmap
Explore
← Back to trials
Trial not found
Could not find
NCT06050252
in the database yet.
Durvalumab With Gemcitabine and Cisplatin for the Treatment of High-Risk Resectable Liver Cancer Before Surgery | AI Cancer Cure